Pickering, B M <br/><br/>
Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.  [electronic resource] 

 -  Oncogene  Feb 2007 
 - 1166-77 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1209897  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ADP-ribosyl Cyclase 1--analysis<br/>Aged<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis<br/>B-Lymphocytes--drug effects<br/>Biomarkers, Tumor--analysis<br/>Caspase 3--analysis<br/>Caspase 9--analysis<br/>Cell Nucleus--chemistry<br/>Cell Survival--drug effects<br/>Diterpenes--pharmacology<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--genetics<br/>MAP Kinase Kinase 4--metabolism<br/>Male<br/>Middle Aged<br/>Myeloid Cell Leukemia Sequence 1 Protein<br/>NF-kappa B--analysis<br/>Neoplasm Proteins--metabolism<br/>Nitriles--pharmacology<br/>Prognosis<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Sulfones--pharmacology<br/>Tumor Cells, Cultured<br/>ZAP-70 Protein-Tyrosine Kinase--analysis